Dualetel Tablet 80/20 mg

Adult dose

Telmisartan: For adults with essential hypertension, it is recommended to take 40 mg orally once daily, and depending on the patient, 20 mg once daily may also be effective. If necessary, the dose can be increased up to 80 mg once daily. For the purpose of reducing the risk of cardiovascular diseases, it is recommended to take 80 mg orally once daily. Patients with liver dysfunction should be cautious not to exceed 40 mg once daily in cases of mild to moderate liver dysfunction.

This medication may cause serious harm or death to the fetus and newborn during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients with hypersensitivity to this medication or who are pregnant, breastfeeding, or have severe liver or kidney disorders should not take it. Patients with a history of muscular disorders, elderly patients, those with hyperkalemia, or liver disorders should take this medication with caution, and regular monitoring and check-ups from a physician are necessary during treatment. This medication may affect liver and kidney function, so liver function tests and serum creatine kinase (CK) levels should be periodically checked before and during administration. If symptoms such as myalgia, muscle weakness, dizziness, or malaise occur during treatment, consult a physician immediately, and in severe cases, the medication may need to be discontinued. This medication may interact with other antihypertensives or lipid-lowering agents, so patients should inform their physician or pharmacist if they are taking other medications. Women who plan to become pregnant or are potentially pregnant should use appropriate contraceptive methods and avoid taking this medication during pregnancy. The safety and efficacy of this medication have not been established in children, so it is advisable not to use it in this population. In case of overdose, symptoms such as hypotension, dizziness, and renal failure may occur; therefore, patients should seek medical attention for appropriate treatment. Drowsiness or dizziness may occur during treatment, so caution should be exercised when driving or operating hazardous machinery. Store out of reach of children and do not transfer to another container for safety.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, mucosal pain in the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, cough with fever-related respiratory changes, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis, urination

Mild side effects

• Dyspepsia
• oral sensory disturbances
• musculoskeletal stiffness
• acne
• itching
• dizziness
• nasopharyngitis
• dysuria
• rhinitis
• pharyngeal discomfort

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain ambient temperatures between 1 degree and 30 degrees celsius for storage. Proper storage can help maintain the medication's effectiveness for a longer duration.

Appearance

Pale pink oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3]